ES2187595T3 - Preparado para la alimentacion. - Google Patents

Preparado para la alimentacion.

Info

Publication number
ES2187595T3
ES2187595T3 ES96112251T ES96112251T ES2187595T3 ES 2187595 T3 ES2187595 T3 ES 2187595T3 ES 96112251 T ES96112251 T ES 96112251T ES 96112251 T ES96112251 T ES 96112251T ES 2187595 T3 ES2187595 T3 ES 2187595T3
Authority
ES
Spain
Prior art keywords
patients
acid
fat
hydrobate
nutrition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96112251T
Other languages
English (en)
Inventor
Albrecht Dipl Oec T Windenband
Gudrun Dipl Hum Biol Pausch
Simone Dr Oec Troph Karsten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
B Braun Melsungen AG
Original Assignee
B Braun Melsungen AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7768555&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2187595(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by B Braun Melsungen AG filed Critical B Braun Melsungen AG
Application granted granted Critical
Publication of ES2187595T3 publication Critical patent/ES2187595T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

EL OBJETIVO DE LA INVENCION DE UN PREPARADO, EN PARTICULAR PREPARADO DE NUTRICION LIQUIDO, PARA NUTRICION ENTERAL Y/O ORAL, EN PARTICULAR PARA PACIENTES DE INMUNOFUNCION DEBILITADA O PACIENTES DE TUMORES, CONTENIENDO ALBUMINA Y/O HIDROLIZADO DE ALBUMINA, HIDRATOS DE CARBONO, GRASA, MATERIAL DE LASTRE Y AGUA CON UN CONTENDIDO EN GRASA DESDE 20 HASTA 30 % DE ENERGIA, DONDE LA MUESTRA DE ACIDO GRASO ABARCA (A) UNA PORCION MCT DE 30 - 70 % (B) UNA RELACION DE {OE}- 3 - ACIDO GRASO CON RESPECTO A {OE} 6 - ACIDO GRASO DE 1 A 3,1 HASTA 1 A 7 (C) UNA RELACION DE {OE} - 6 - ACIDO GRASO A {OE} - 9 - ACIDO GRASO DE 1 A 0,7 HASTA 1 A 1,4 Y (D) UNA RELACION DE LOS ACIDO GRASOS NO SATURADOS CON RESPECTO A ACIDOS GRASOS NO SATURADOS MULTIPLES DE 1 A 0,5 HASTA 1 A 1,5, DONDE LOS COMPONENTES DE ALBUMINA ABARCAN 0,5 - 3,0 G DE GLUTAMINA POR CADA 100 ML DE SOLUCION ELABORADA DE UTILIZACION. UNA OTRA FORMA DE ACUERDO CON LA INVENCION SE REFIERE A LA UTILIZACION DE LOS PREPARADOS ANTES INDICADOS PARA NUTRICIONDE PACIENTES CON INMUNOFUNCIONES DE CRECIMIENTO, PACIENTES DE TUMORES, PACIENTES CON INFECCION HIV, PACIENTES EN LA FASE POSTOPERATIVA, PACIENTES SEPTICOS, PACIENTES CON PREVISION DE INFLAMACION PRO-INFLAMATORICA Y/O PACIENTES CON ENFERMEDADES INTESTINALES DE INFLAMACION.
ES96112251T 1995-08-03 1996-07-30 Preparado para la alimentacion. Expired - Lifetime ES2187595T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19528461A DE19528461A1 (de) 1995-08-03 1995-08-03 Präparat zur Ernährung

Publications (1)

Publication Number Publication Date
ES2187595T3 true ES2187595T3 (es) 2003-06-16

Family

ID=7768555

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96112251T Expired - Lifetime ES2187595T3 (es) 1995-08-03 1996-07-30 Preparado para la alimentacion.

Country Status (4)

Country Link
EP (1) EP0756827B1 (es)
JP (1) JPH09121809A (es)
DE (2) DE19528461A1 (es)
ES (1) ES2187595T3 (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007063141A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Producto alimenticio para la nutrición por vía enteral u oral
WO2007063143A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Mezcla de lipidos y su utilización para preparar un producto destinado a la adminitracion enteral u oral

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09194364A (ja) * 1996-01-22 1997-07-29 Snow Brand Milk Prod Co Ltd ビタミンａ吸収促進剤
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US5891925A (en) * 1997-06-27 1999-04-06 Abbott Laboratories Diagnostic method for assessing the serum cholesterol response to low diets
DE19757414A1 (de) * 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
ATE322275T1 (de) * 1998-06-10 2006-04-15 Albert B Crum Vorbeugender und therapeutischer nahrungsmittelzusatz zur schaffung/erhaltung einer die gesundheit schützenden darmmikroflora und zur stärkung des immunsystems
JP3727538B2 (ja) * 1998-08-03 2005-12-14 イー ホウィーラー，ロナルド 前立腺配合物
FR2806879B1 (fr) * 2000-03-30 2004-04-30 Amalric Veret Une nouvelle formule de complement nutritionnel composee de cinq huiles (bourrache, onagre, carotte, avocat, tomate)
JP2002119250A (ja) * 2000-10-17 2002-04-23 Nisshin Pharma Inc 栄養組成物
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
DE10221403A1 (de) * 2002-05-14 2003-12-04 Kyberg Pharma Vertriebs Gmbh & Diätetische und pharmazeutische Zusammensetzungen, ihre Herstellung und ihre Verwendung
DE20215514U1 (de) 2002-10-09 2003-01-02 Bartz, Volker, 35440 Linden Diätetisches Lebensmittel zur Behandlung von Niereninsuffizienz
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
BRPI0509736A (pt) * 2004-04-09 2007-09-25 Nutricia Nv composição nutricional completa lìquida adequada para alimentar pacientes caquéticos, produto alimentìcio acondicionado, pó, e, processo para a preparação de um produto lìquido
US20060251634A1 (en) 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
ES2548432T3 (es) 2005-12-19 2015-10-16 Abbott Laboratories Uso de beta-hidroxi-beta-metilbutirato para modular el desequilibrio en la producción de citoquinas de tipo 1 y tipo 2
BRPI0706795A2 (pt) * 2006-01-31 2011-04-05 Nestec Sa composição nutricional para bebês com baixo peso de nascimento
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
WO2011071365A1 (en) 2009-12-07 2011-06-16 N.V. Nutricia Balanced fat composition and use thereof in a liquid nutritional composition suitable for enteral feeding
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
BR112012018174A2 (pt) 2010-01-29 2019-08-27 Abbott Lab líquidos nutricionais embalados assepticamente compreendendo hmb.
JP5892948B2 (ja) 2010-01-29 2016-03-23 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ カルシウムｈｍｂを含む栄養エマルジョン
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
JP6935994B2 (ja) 2016-08-19 2021-09-15 株式会社明治 ケトン体生成促進用組成物
CN108402466A (zh) * 2017-02-10 2018-08-17 台湾原生药用植物股份有限公司 含不饱和脂肪酸的素食组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814806A1 (de) * 1988-05-02 1989-11-16 Christoph V Dr Rer Nat Stein Verfahren zur stabilisierung von aminosaeuren-infusionsloesungen
DE68904874T2 (de) * 1988-10-31 1993-07-15 Sandoz Nutrition Ltd Organische verbindungen.
ATE192037T1 (de) * 1989-12-29 2000-05-15 Braun Medical Inc Verwendung von arginin als immunstimulator
US5221668A (en) * 1992-02-26 1993-06-22 Abbott Laboratories Nutritional product for trauma and surgery patients
DE4304394A1 (en) * 1993-02-13 1993-09-02 Fresenius Ag Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins
NZ248603A (en) * 1993-05-28 1994-12-22 Abbott Lab Nutritional product for enteral nutritional support of hiv victims comprising proteins and fat
US5514655A (en) * 1993-05-28 1996-05-07 Abbott Laboratories Enteral nutritional with protein system containing soy protein hydrolysate and intact protein
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
DE4417851C1 (de) * 1994-05-20 1995-10-05 Horst Heirler Diätetisches Lebensmittel mit mittelkettigen Fettsäuren und dessen Verwendung

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007063141A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Producto alimenticio para la nutrición por vía enteral u oral
WO2007063143A1 (es) * 2005-11-30 2007-06-07 Katry Inversiones, S.L. Mezcla de lipidos y su utilización para preparar un producto destinado a la adminitracion enteral u oral

Also Published As

Publication number Publication date
EP0756827A3 (de) 1997-09-17
DE59609906D1 (de) 2003-01-09
DE19528461A1 (de) 1997-02-06
EP0756827A2 (de) 1997-02-05
JPH09121809A (ja) 1997-05-13
EP0756827B1 (de) 2002-11-27

Similar Documents

Publication Publication Date Title
ES2187595T3 (es) Preparado para la alimentacion.
DK0764405T3 (da) Ernæringspræparat
ES511433A0 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
NO863935L (no) Fremgangsmaate for fremstilling av terapeutiske preparater inneholdende 2-(2-fluor-4-bifenylyl)propionsyre.
PT74586B (en) Process for the preparation emulsions of the tyre oil-in-water specially appropriate for being used as formulations of agro- chemical compositions for combating pests in the domestic field and hygiene field and/or of pharmaceutical compositions
ITMI922842A0 (it) Procedimento per la preparazione di una composizione farmaceutica che abbassa selettivamente il livello di lipidi nel sangue
DE68909409D1 (de) Heilmitteldosierung zur verabreichung an fische.
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
ITRM930365A0 (it) Uso di esteri sull'ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.
MX9305143A (es) Composiciones nutritivas o medicamentos a base de quitosana, para la administracion de los rumiantes y procedimiento para su preparacion.
FR2641189B1 (fr) Compositions pharmaceutiques contenant de l'acide acetyl salicylique et de la vitamine b6
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
DK148788A (da) Farmaceutisk praeparat indeholdende polyumaettede fedtsyrer
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
FR2578745B1 (fr) Preparations pharmaceutiques fluidifiant le sang
FI890820A0 (fi) Menetelmä jäätelön muodossa olevan ravinnelisän valmistamiseksi sairaanhoidollisiin tarkoituksiin
FI944229A0 (fi) Astyylisalisyylihappoon tai sen suoloihin perustuva puristettu farmaseuttinen annosmuoto oraalista antoa varten ja menetelmä sen valmistamiseksi
ITMI932706A0 (it) Unguento farmaceutico privo di azione irritativa della pelle e procedimento per la sua preparazione
Guembel Change of arachidonic acid and docosa-hexaen acid speculum in the serum of people having heart trouble on a coronary diet with mackerel.).
RU97115999A (ru) Аминокислотные композиции и их применение в лечебном питании
RU94005013A (ru) Применение йод-лактонов эйкозапентаеновой и докозагексаеновой кислот в качестве противоожогового средства
HU901411D0 (en) Solution and cream containing vegetable drug extracts for the soothing of rheumatic pain
IT1270699B (it) Sali dell'acido s(+)-2-(4-isobutilfenil)propionico con mono-, di- e trialcanolammine
MX9304553A (es) Complejo de ibuprofen-beta-ciclodextrina para la fabricacion de unmedicamento de consumo oral, procedimiento para su preparacion ycomposiciones farmaceuticas que lo contienen.
TH58453A (th) การบำบัดของกรดไขมัน